A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants With Parkinson's Disease
Status:
Recruiting
Trial end date:
2025-11-13
Target enrollment:
Participant gender:
Summary
The goal of this study is to test KM-819 in halting or slowing the progression of Parkinson's
disease.
The study evaluates the safety and tolerability of multiple ascending doses of KM-819 in
healthy older adults and participants with Parkinson's disease.